$SYNA
SYNAPTICS Inc Stock $syna

$syna Overview Financials Valuation SEC Filings Company Website

2019 Q2 Form 10-K Financial Statement

#000156459020040946 Filed on August 21, 2020

Income Statement

Concept	2019 Q2	2019	2018 Q2
Revenue	$295.1M	$1.472B	$388.5M
YoY Change	-24.04%	-9.7%	-8.91%
Cost Of Revenue	$204.7M	$975.1M	$260.9M
YoY Change	-21.54%	-15.22%	-12.95%
Gross Profit	$90.40M	$497.1M	$127.6M
YoY Change	-29.15%	3.54%	0.63%
Gross Profit Margin	30.63%	33.77%	32.84%
Selling, General & Admin	$26.80M	$131.3M	$38.40M
YoY Change	-30.21%	-14.74%	17.79%
% of Gross Profit	29.65%	26.41%	30.09%
Research & Development	$84.20M	$342.7M	$90.20M
YoY Change	-6.65%	-5.64%	22.22%
% of Gross Profit	93.14%	68.94%	70.69%
Depreciation & Amortization	$26.40M	$110.0M	$32.20M
YoY Change	-18.01%	-10.42%	44.39%
% of Gross Profit	29.2%	22.13%	25.24%
Operating Expenses	$113.9M	$503.4M	$132.9M
YoY Change	-14.3%	-7.12%	22.15%
Operating Profit	-$23.50M	-$6.300M	-$5.300M
YoY Change	343.4%	-89.82%	-129.44%
Interest Expense	-$6.800M	$21.20M	-$4.500M
YoY Change	51.11%	-4.5%	28.57%
% of Operating Profit
Other Income/Expense, Net	$2.800M	$3.900M
YoY Change
Pretax Income	-$37.30M	-$20.80M	-$13.20M
YoY Change	182.58%	-74.57%	-180.49%
Income Tax	$8.400M	$300.0K	-$7.300M
% Of Pretax Income
Net Earnings	-$46.20M	-$22.90M	-$1.500M
YoY Change	2980.0%	-81.55%	-108.43%
Net Earnings / Revenue	-15.66%	-1.56%	-0.39%
Basic Earnings Per Share		-$0.66
Diluted Earnings Per Share	-$1.347M	-$0.66	-$43.10K
COMMON SHARES
Basic Shares Outstanding	34.50M	34.60M
Diluted Shares Outstanding		34.60M

Balance Sheet

Concept	2019 Q2	2019	2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$327.8M	$327.8M	$301.0M
YoY Change	8.9%	8.9%	-18.16%
Cash & Equivalents	$327.8M	$327.8M	$301.0M
Short-Term Investments
Other Short-Term Assets	$14.60M	$14.60M	$18.20M
YoY Change	-19.78%	-19.78%	-51.6%
Inventory	$158.7M	$158.7M	$131.2M
Prepaid Expenses
Receivables	$230.0M	$230.0M	$289.1M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$731.1M	$731.1M	$739.5M
YoY Change	-1.14%	-1.14%	-6.63%
LONG-TERM ASSETS
Property, Plant & Equipment	$103.0M	$103.0M	$117.8M
YoY Change	-12.56%	-12.56%	3.51%
Goodwill	$372.8M		$372.8M
YoY Change	0.0%		80.27%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$58.10M	$58.10M	$50.50M
YoY Change	15.05%	15.05%	-4.9%
Total Long-Term Assets	$678.7M	$678.7M	$760.3M
YoY Change	-10.73%	-10.73%	60.16%
TOTAL ASSETS
Total Short-Term Assets	$731.1M	$731.1M	$739.5M
Total Long-Term Assets	$678.7M	$678.7M	$760.3M
Total Assets	$1.410B	$1.410B	$1.500B
YoY Change	-6.0%	-6.0%	18.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$98.30M	$98.30M	$156.9M
YoY Change	-37.35%	-37.35%	15.54%
Accrued Expenses	$136.5M	$136.5M	$105.1M
YoY Change	29.88%	29.88%	-21.39%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$253.9M	$253.9M	$283.8M
YoY Change	-10.54%	-10.54%	-8.57%
LONG-TERM LIABILITIES
Long-Term Debt	$468.3M	$468.3M	$450.7M
YoY Change	3.91%	3.91%	123.12%
Other Long-Term Liabilities	$30.30M	$30.30M	$36.00M
YoY Change	-15.83%	-15.83%	155.32%
Total Long-Term Liabilities	$30.30M	$498.6M	$36.00M
YoY Change	-15.83%	2.45%	155.32%
TOTAL LIABILITIES
Total Short-Term Liabilities	$253.9M	$253.9M	$283.8M
Total Long-Term Liabilities	$30.30M	$498.6M	$36.00M
Total Liabilities	$752.5M	$752.5M	$770.5M
YoY Change	-2.34%	-2.34%	46.34%
SHAREHOLDERS EQUITY
Retained Earnings	$583.5M		$606.4M
YoY Change	-3.78%		-15.08%
Common Stock	$1.266B		$1.195B
YoY Change	5.93%		18.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.192B		$1.074B
YoY Change	11.03%		9.55%
Treasury Stock Shares
Shareholders Equity	$656.4M	$657.3M	$729.3M
YoY Change
Total Liabilities & Shareholders Equity	$1.410B	$1.410B	$1.500B
YoY Change	-6.0%	-6.0%	18.4%

Cashflow Statement

Concept	2019 Q2	2019	2018 Q2
OPERATING ACTIVITIES
Net Income	-$46.20M	-$22.90M	-$1.500M
YoY Change	2980.0%	-81.55%	-108.43%
Depreciation, Depletion And Amortization	$26.40M	$110.0M	$32.20M
YoY Change	-18.01%	-10.42%	44.39%
Cash From Operating Activities	$43.40M	$154.2M	$7.900M
YoY Change	449.37%	6.34%	-83.68%
INVESTING ACTIVITIES
Capital Expenditures	-$6.000M	$23.70M	-$6.600M
YoY Change	-9.09%	-30.5%	24.53%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$2.800M	-$300.0K
YoY Change	-100.0%	-100.71%	-88.46%
Cash From Investing Activities	-$6.000M	-$20.90M	-$6.900M
YoY Change	-13.04%	-95.23%	-12.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$118.5M
YoY Change		26.6%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-33.50M	-106.6M	16.70M
YoY Change	-300.6%	-147.02%	-978.95%
NET CHANGE
Cash From Operating Activities	43.40M	154.2M	7.900M
Cash From Investing Activities	-6.000M	-20.90M	-6.900M
Cash From Financing Activities	-33.50M	-106.6M	16.70M
Net Change In Cash	3.900M	26.80M	17.70M
YoY Change	-77.97%	-140.12%	-54.15%
FREE CASH FLOW
Cash From Operating Activities	$43.40M	$154.2M	$7.900M
Capital Expenditures	-$6.000M	$23.70M	-$6.600M
Free Cash Flow	$49.40M	$130.5M	$14.50M
YoY Change	240.69%	17.67%	-73.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020	us-gaap	Lessee Operating Lease Existence Of Option To Extend LesseeOperatingLeaseExistenceOfOptionToExtend	true
CY2020Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2019Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2020	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P4Y4M24D
CY2020Q2	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	us-gaap:OperatingLeaseLiabilityNoncurrent
CY2020Q2	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	us-gaap:OperatingLeaseLiability
CY2020Q2	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	us-gaap:OperatingLeaseLiability
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2020	dei	Security12b Title Security12bTitle	Common Stock, par value $.001 per share
CY2020	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020	us-gaap	Stock Repurchase Program Expiration Date StockRepurchaseProgramExpirationDate	2020-07-31
CY2020Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:OperatingLeaseLiabilityCurrent
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	327800000
CY2019Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	230000000.0
CY2019Q2	us-gaap	Inventory Net InventoryNet	158700000
CY2019Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14600000
CY2019Q2	us-gaap	Assets Current AssetsCurrent	731100000
CY2019Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	103000000.0
CY2019Q2	us-gaap	Goodwill Goodwill	372800000
CY2019Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	144800000
CY2019Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	58100000
CY2019Q2	us-gaap	Assets Assets	1409800000
CY2019Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	98300000
CY2019Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	30400000
CY2019Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	19100000
CY2019Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	106100000
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1150200000
CY2018	us-gaap	Gross Profit GrossProfit	480100000
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	363200000
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.54
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.66
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34200000
CY2018	syna	Amortization Of Intangible Assets Included In Operating Expense AmortizationOfIntangibleAssetsIncludedInOperatingExpense	12800000
CY2018	us-gaap	Restructuring Charges RestructuringCharges	12000000.0
CY2020	us-gaap	Operating Expenses OperatingExpenses	474200000
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2000000.0
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	68900000
CY2020Q2	us-gaap	Liabilities Liabilities	874700000
CY2019Q2	us-gaap	Liabilities Liabilities	752500000
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	763400000
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5800000
CY2019Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2100000
CY2020Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	195300000
CY2020Q2	us-gaap	Inventory Net InventoryNet	102000000.0
CY2020Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16900000
CY2020Q2	us-gaap	Assets Current AssetsCurrent	1077600000
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	84300000
CY2020Q2	us-gaap	Goodwill Goodwill	360800000
CY2020Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	93400000
CY2020Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	77700000
CY2020Q2	us-gaap	Assets Assets	1693800000
CY2020Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	60600000
CY2020Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	59500000
CY2020Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	33000000.0
CY2020Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	91000000.0
CY2020Q2	us-gaap	Liabilities Current LiabilitiesCurrent	244100000
CY2019Q2	us-gaap	Liabilities Current LiabilitiesCurrent	253900000
CY2020Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	100000000.0
CY2020Q2	syna	Convertible Notes Payable Net ConvertibleNotesPayableNet	486600000
CY2019Q2	syna	Convertible Notes Payable Net ConvertibleNotesPayableNet	468300000
CY2020Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	44000000.0
CY2019Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	30300000
CY2020Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2019Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2020Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2019Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2019Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	120000000
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	120000000
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	65871648
CY2019Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	64283948
CY2019	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1500000
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	154000000.0
CY2020	syna	Amortization Of Intangible Assets Included In Operating Expense AmortizationOfIntangibleAssetsIncludedInOperatingExpense	11700000
CY2019	syna	Amortization Of Intangible Assets Included In Operating Expense AmortizationOfIntangibleAssetsIncludedInOperatingExpense	11700000
CY2019	us-gaap	Restructuring Charges RestructuringCharges	17700000
CY2019	us-gaap	Operating Expenses OperatingExpenses	503400000
CY2018	us-gaap	Operating Expenses OperatingExpenses	542000000.0
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-6300000
CY2020	us-gaap	Restructuring Charges RestructuringCharges	33000000.0
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34122453
CY2019Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33349735
CY2020Q2	us-gaap	Common Stock Value CommonStockValue	100000
CY2019Q2	us-gaap	Common Stock Value CommonStockValue	100000
CY2020Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1340200000
CY2019Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1266100000
CY2020Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	31749195
CY2019Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	30934213
CY2020Q2	us-gaap	Treasury Stock Value TreasuryStockValue	1222600000
CY2019Q2	us-gaap	Treasury Stock Value TreasuryStockValue	1192400000
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	701400000
CY2019Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	583500000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	819100000
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	657300000
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1693800000
CY2019Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1409800000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1333900000
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1472200000
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1630300000
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	790800000
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	975100000
CY2020	us-gaap	Gross Profit GrossProfit	543100000
CY2019	us-gaap	Gross Profit GrossProfit	497100000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	302500000
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	342700000
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	127000000.0
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	131300000
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-61900000
CY2020	us-gaap	Interest Income Other InterestIncomeOther	7900000
CY2019	us-gaap	Interest Income Other InterestIncomeOther	3900000
CY2018	us-gaap	Interest Income Other InterestIncomeOther	2300000
CY2020	us-gaap	Interest Expense InterestExpense	22500000
CY2019	us-gaap	Interest Expense InterestExpense	21200000
CY2018	us-gaap	Interest Expense InterestExpense	22200000
CY2020	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	105100000
CY2019	us-gaap	Gain Loss On Investments GainLossOnInvestments	2800000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	159400000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-20800000
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-81800000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	38600000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40500000
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1800000
CY2018	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1800000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	118800000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-22900000
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.66
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.63
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.63
CY2020	syna	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Adjustments For Performance Results Attained ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsForPerformanceResultsAttained	58707
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward	346502
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-124100000
CY2017Q2	us-gaap	New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Equity Or Net Assets1 NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1	25700000
CY2017Q2	syna	Cumulative Effect On Retained Earnings Tax CumulativeEffectOnRetainedEarningsTax	8300000
CY2018	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	32300000
CY2018	syna	Payroll Taxes For Deferred Stock Units PayrollTaxesForDeferredStockUnits	5400000
CY2018	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	93600000
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	71300000
CY2018	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	52100000
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	729300000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-22900000
CY2019	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1500000
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	21300000
CY2019	syna	Payroll Taxes For Deferred Stock Units PayrollTaxesForDeferredStockUnits	9400000
CY2019	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	118500000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	59000000.0
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	657300000
CY2019Q2	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	-900000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	118800000
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	34500000
CY2020	syna	Payroll Taxes For Deferred Stock Units PayrollTaxesForDeferredStockUnits	9700000
CY2020	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	30200000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	49300000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	819100000
CY2020	us-gaap	Profit Loss ProfitLoss	118800000
CY2019	us-gaap	Profit Loss ProfitLoss	-22900000
CY2018	us-gaap	Profit Loss ProfitLoss	-124100000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	49300000
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	59000000.0
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	71300000
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	26700000
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	35600000
CY2018	us-gaap	Depreciation And Amortization DepreciationAndAmortization	38900000
CY2020	syna	Acquired Intangibles Amortization AcquiredIntangiblesAmortization	51400000
CY2019	syna	Acquired Intangibles Amortization AcquiredIntangiblesAmortization	74400000
CY2018	syna	Acquired Intangibles Amortization AcquiredIntangiblesAmortization	83900000
CY2020	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	105100000
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1200000
CY2020	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-2700000
CY2019	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	15200000
CY2018	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-4900000
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	18300000
CY2019	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	17600000
CY2018	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	16900000
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	600000
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	500000
CY2018	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1600000
CY2019	us-gaap	Gain Loss On Investments GainLossOnInvestments	2800000
CY2020	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	2400000
CY2019	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	-1900000
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2000000.0
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1800000
CY2018	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1800000
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3700000
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-400000
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-100000
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-31000000.0
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-64300000
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	22700000
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-43000000.0
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	27500000
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-79500000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2900000
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3600000
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-18800000
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-3900000
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-3900000
CY2018	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	7200000
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-36200000
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-55800000
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	6200000
CY2020	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	29100000
CY2019	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	4900000
CY2018	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-8100000
CY2019	syna	Increase Decrease In Acquisition Related Liabilities IncreaseDecreaseInAcquisitionRelatedLiabilities	-6800000
CY2020	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	13800000
CY2019	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	900000
CY2018	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	5400000
CY2020	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-29900000
CY2019	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	20500000
CY2018	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-22100000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	221800000
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	154200000
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	145000000.0
CY2020	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	138700000
CY2020	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	2500000
CY2018	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	396700000
CY2019	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	2800000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16300000
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23700000
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	34100000
CY2018	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	7700000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	119900000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-20900000
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-438500000
CY2018	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	514500000
CY2020	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	100000000.0
CY2018	us-gaap	Repayments Of Debt RepaymentsOfDebt	220000000.0
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	30200000
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	118500000
CY2018	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	93600000
CY2020	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	34500000
CY2019	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	21300000
CY2018	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	32300000
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	700000
CY2018	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1100000
CY2020	syna	Payment For Payroll Taxes For Deferred Stock And Market Stock Units PaymentForPayrollTaxesForDeferredStockAndMarketStockUnits	9700000
CY2019	syna	Payment For Payroll Taxes For Deferred Stock And Market Stock Units PaymentForPayrollTaxesForDeferredStockAndMarketStockUnits	9400000
CY2018	syna	Payment For Payroll Taxes For Deferred Stock And Market Stock Units PaymentForPayrollTaxesForDeferredStockAndMarketStockUnits	5400000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	93900000
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-106600000
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	226700000
CY2019	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	100000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	435600000
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	26800000
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-66800000
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	327800000
CY2018Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	301000000.0
CY2017Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	367800000
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	763400000
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	327800000
CY2018Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	301000000.0
CY2020	us-gaap	Interest Paid Net InterestPaidNet	3700000
CY2019	us-gaap	Interest Paid Net InterestPaidNet	3600000
CY2018	us-gaap	Interest Paid Net InterestPaidNet	3800000
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	18900000
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	16400000
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid	26400000
CY2020	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	1300000
CY2019	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	6400000
CY2018	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	1700000
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1200000
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3800000
CY2018	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	6600000
CY2018	us-gaap	Stock Issued1 StockIssued1	39100000
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.86%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to revenue, allowance for doubtful accounts, cost of revenue, inventories, loss on purchase commitments, product warranty, accrued liabilities, share-based compensation costs, provision for income taxes, deferred income tax asset valuation allowances, uncertain tax positions, goodwill, intangible assets, investments, contingent consideration liability and loss contingencies. We base our estimates on historical experience, applicable laws and regulations, and various other assumptions that we believe to be reasonable under the circumstances, including our expectations regarding the potential impacts on our business of the COVID-19 pandemic, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</p>
CY2020Q2	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0
CY2019Q2	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0
CY2020Q2	us-gaap	Fair Value Assets Level2 To Level1 Transfers Amount FairValueAssetsLevel2ToLevel1TransfersAmount	0
CY2019Q2	us-gaap	Fair Value Assets Level2 To Level1 Transfers Amount FairValueAssetsLevel2ToLevel1TransfersAmount	0
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0
CY2019	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0
CY2019	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0
CY2020	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.86%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash equivalents, investments, and accounts receivable. Our investment policy, which is predicated on capital preservation and liquidity, limits investments to U.S. government treasuries and agency issues, taxable securities, and municipal issued securities with a minimum rating of A1 (Moody’s) or P1 (Standard and Poor’s) or their equivalent. </p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:4.86%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We sell our products to contract manufacturers that provide manufacturing services for OEMs, to some OEMs directly, and to distributors. We extend credit based on an evaluation of a customer’s financial condition, and we generally do not require collateral.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:4.86%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following customers accounted for more than 10% of our accounts receivable balance as of the end of fiscal 2020 and 2019:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer A</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer B</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer C</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer D</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-right:89.29%;text-indent:0%;font-size:6pt;font-family:Times New Roman;"> </p> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:3.57%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-top:2pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</span></p></td> <td valign="top"> <p style="text-align:justify;margin-top:2pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Less than 10%</p></td></tr></table></div>
CY2020	us-gaap	Revenue Performance Obligation Description Of Payment Terms RevenuePerformanceObligationDescriptionOfPaymentTerms	Payments are generally due within three months of completion of the performance obligation and subsequent invoicing and, therefore, do not include significant financing components.
CY2020	syna	Account Receivable Bad Debt Charge AccountReceivableBadDebtCharge	0
CY2020Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	400000
CY2019Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	900000
CY2020Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3200000
CY2020Q2	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	25800000
CY2019Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4500000
CY2019Q2	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	47500000
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2000000.0
CY2019	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	300000
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3700000
CY2020Q2	us-gaap	Inventory Work In Process And Raw Materials Net Of Reserves InventoryWorkInProcessAndRawMaterialsNetOfReserves	53600000
CY2019Q2	us-gaap	Inventory Work In Process And Raw Materials Net Of Reserves InventoryWorkInProcessAndRawMaterialsNetOfReserves	110700000
CY2020Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	48400000
CY2019Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	48000000.0
CY2020Q2	us-gaap	Inventory Net InventoryNet	102000000.0
CY2019Q2	us-gaap	Inventory Net InventoryNet	158700000
CY2020	syna	Foreign Currency Transaction Realized And Unrealized Gain Loss Net Of Tax ForeignCurrencyTransactionRealizedAndUnrealizedGainLossNetOfTax	200000
CY2019	syna	Foreign Currency Transaction Realized And Unrealized Gain Loss Net Of Tax ForeignCurrencyTransactionRealizedAndUnrealizedGainLossNetOfTax	-1100000
CY2018	syna	Foreign Currency Transaction Realized And Unrealized Gain Loss Net Of Tax ForeignCurrencyTransactionRealizedAndUnrealizedGainLossNetOfTax	-1100000
CY2019Q2	us-gaap	Goodwill Goodwill	372800000
CY2018Q2	us-gaap	Goodwill Goodwill	372800000
CY2020	syna	Goodwill Allocated To Sale Of Product Line GoodwillAllocatedToSaleOfProductLine	-12000000.0
CY2019	syna	Goodwill Allocated To Sale Of Product Line GoodwillAllocatedToSaleOfProductLine	0
CY2020Q2	us-gaap	Goodwill Goodwill	360800000
CY2019Q2	us-gaap	Goodwill Goodwill	372800000
CY2020	us-gaap	Number Of Reporting Units NumberOfReportingUnits	2
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2018	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2019Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	31100000
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2900000
CY2020Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	44000000.0
CY2020Q2	syna	Customer Obligation CustomerObligation	29000000.0
CY2019Q2	syna	Customer Obligation CustomerObligation	52000000.0
CY2020Q2	syna	Accrued Liabilities For Inventory Purchase AccruedLiabilitiesForInventoryPurchase	27900000
CY2019Q2	syna	Accrued Liabilities For Inventory Purchase AccruedLiabilitiesForInventoryPurchase	26700000
CY2020Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	3900000
CY2019Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	4000000.0
CY2020Q2	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	30200000
CY2019Q2	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	23400000
CY2020Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	91000000.0
CY2019Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	106100000
CY2020Q2	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	16400000
CY2019Q2	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	16200000
CY2020Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	14600000
CY2020Q2	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	13000000.0
CY2019Q2	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	14100000
CY2019Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	30300000
CY2020	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P7Y
CY2020	us-gaap	Net Income Loss NetIncomeLoss	118800000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-22900000
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-124100000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33600000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34600000
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	10500000
CY2018	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	900000
CY2018Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	24800000
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34200000
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1200000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34800000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34600000
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34200000
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.54
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.66
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.63
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.41
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.66
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.63
CY2020Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	215500000
CY2019Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	236100000
CY2020Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	131200000
CY2019Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	133100000
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	84300000
CY2019Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	103000000.0
CY2020	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	16600000
CY2019	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	16800000
CY2020Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	398300000
CY2020Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	304900000
CY2020Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	93400000
CY2019Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	445500000
CY2019Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	300700000
CY2019Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	144800000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	51400000
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	74400000
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	83900000
CY2020Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	37500000
CY2020Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	32900000
CY2020Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	20400000
CY2020Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2500000
CY2020Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	100000
CY2020Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	93400000
CY2020	syna	Percentage Of Voting Capital Stock Of Certain Foreign Subsidiaries Collateralized PercentageOfVotingCapitalStockOfCertainForeignSubsidiariesCollateralized	0.65
CY2019Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	27800000
CY2019Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	28400000
CY2020	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	The leases expire at various dates through fiscal year 2028, some of which include options to extend the lease for up to 5 years.
CY2020	syna	Lease Expiration Year LeaseExpirationYear	2028
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	8800000
CY2020Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	21000000.0
CY2020Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6500000
CY2020Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	14600000
CY2020Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	21100000
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	8400000
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2900000
CY2020Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y1M2D
CY2020Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0401
CY2020Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	7200000
CY2020Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	6700000
CY2020Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	3600000
CY2020Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	2100000
CY2020Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1100000
CY2020Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	2100000
CY2020Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	22800000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1700000
CY2020Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	21100000
CY2019	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	10300000
CY2018	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	12000000.0
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	7400000
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	3200000
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	900000
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	300000
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	100000
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	11900000
CY2020Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2020Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3190152
CY2020Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	5605642
CY2020Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	177400000
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	2891466
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	3508175
CY2020	syna	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Restricted Stock Units Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRestrictedStockUnitsGrantsInPeriod	742586
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	359336
CY2020	syna	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Performance Stock Units Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceStockUnitsGrantsInPeriod	335966
CY2020	syna	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Adjustments For Performance Stock Units ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsForPerformanceStockUnits	10242
CY2020	syna	Share Based Compensation Arrangement By Share Based Payment Awards Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardsForfeituresInPeriod	1186383
CY2020	syna	Share Based Compensation Arrangement By Share Based Payment Award Fungible Shares Ratio Adjustment ShareBasedCompensationArrangementByShareBasedPaymentAwardFungibleSharesRatioAdjustment	308424
CY2020	syna	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Unavailable For Grant Upon Expiration Of Plan ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnavailableForGrantUponExpirationOfPlan	2371402
CY2020	syna	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Cancelled ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesCancelled	605
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3190152
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	60400000
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	59000000.0
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	71300000
CY2020	syna	Employee Service Share Based Compensation Tax Benefit Expense From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitExpenseFromCompensationExpense	6300000
CY2019	syna	Employee Service Share Based Compensation Tax Benefit Expense From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitExpenseFromCompensationExpense	4300000
CY2018	syna	Employee Service Share Based Compensation Tax Benefit Expense From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitExpenseFromCompensationExpense	11100000
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1191929
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	59.07
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	542776
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	44.03
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	8117
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	50.70
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	311250
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	74.16
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	329786
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	69.78
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	400000
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	329057
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	69.83
CY2020Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	400000
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	23900000
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5200000
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	16700000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	10800000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2400000
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	15200000
CY2020	syna	Stock Purchases Under Employee Stock Purchase Plan As Compensation Maximum Subject To Legal Restrictions And Limitations StockPurchasesUnderEmployeeStockPurchasePlanAsCompensationMaximumSubjectToLegalRestrictionsAndLimitations	0.15
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	20400000
CY2020	syna	Employee Common Stock Purchases Through Payroll Deductions Under Employee Stock Purchase Plan Price As Percentage Of Fair Market Value EmployeeCommonStockPurchasesThroughPayrollDeductionsUnderEmployeeStockPurchasePlanPriceAsPercentageOfFairMarketValue	0.85
CY2020	syna	Offering Period Extends Under Employee Stock Purchase Plan OfferingPeriodExtendsUnderEmployeeStockPurchasePlan	up to two years
CY2020	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	19500
CY2020	syna	Defined Contribution Plans Eligible Employee Contributions Employees Fifty And Over Annual Limit DefinedContributionPlansEligibleEmployeeContributionsEmployeesFiftyAndOverAnnualLimit	26000
CY2020	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.25
CY2020	syna	Contributions By Employer Matching Contributions ContributionsByEmployerMatchingContributions	2100000
CY2019	syna	Contributions By Employer Matching Contributions ContributionsByEmployerMatchingContributions	2400000
CY2018	syna	Contributions By Employer Matching Contributions ContributionsByEmployerMatchingContributions	2800000
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2817
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	159400000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20800000
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-81800000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	36200000
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	800000
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-4900000
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	21500000
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	35400000
CY2018	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	14100000
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	15500000
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	35600000
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-5800000
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-8500000
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	14400000
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	100000
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	8100000
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-6700000
CY2018	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-9500000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2400000
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-15200000
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4900000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	38600000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40500000
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	33500000
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4400000
CY2018	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-22900000
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	3000000.0
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	4000000.0
CY2018	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	4900000
CY2020	syna	Effective Income Tax Rate Reconciliation Share Based Compensation Shortfall Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationShortfallAmount	-2100000
CY2019	syna	Effective Income Tax Rate Reconciliation Share Based Compensation Shortfall Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationShortfallAmount	-3300000
CY2018	syna	Effective Income Tax Rate Reconciliation Share Based Compensation Shortfall Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationShortfallAmount	-4100000
CY2020	syna	Income Tax Reconciliation Non Deductible Compensation IncomeTaxReconciliationNonDeductibleCompensation	1900000
CY2019	syna	Income Tax Reconciliation Non Deductible Compensation IncomeTaxReconciliationNonDeductibleCompensation	1100000
CY2020	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	6100000
CY2019	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	6100000
CY2018	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	4900000
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	4900000
CY2019	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	1000000.0
CY2018	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	16500000
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Amortization IncomeTaxReconciliationNondeductibleExpenseAmortization	700000
CY2018	us-gaap	Income Tax Reconciliation Nondeductible Expense Amortization IncomeTaxReconciliationNondeductibleExpenseAmortization	1200000
CY2018	us-gaap	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Provisional Income Tax Expense Benefit TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit	44100000
CY2018	us-gaap	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Provisional Income Tax Expense Benefit TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit	-2700000
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-700000
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	700000
CY2018	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	200000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	38600000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40500000
CY2020Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	4000000.0
CY2019Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	12100000
CY2020Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	1200000
CY2019Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	1500000
CY2020Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	3400000
CY2019Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	800000
CY2020Q2	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	600000
CY2019Q2	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	500000
CY2020Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6800000
CY2019Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	9500000
CY2020Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	41300000
CY2019Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	37300000
CY2020Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	6600000
CY2019Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	7000000.0
CY2020Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	5200000
CY2019Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	3300000
CY2020Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	69100000
CY2019Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	72000000.0
CY2020Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	33300000
CY2019Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	30400000
CY2020Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	35800000
CY2019Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	41600000
CY2020Q2	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Interest DeferredTaxLiabilitiesDeferredExpenseCapitalizedInterest	7100000
CY2019Q2	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Interest DeferredTaxLiabilitiesDeferredExpenseCapitalizedInterest	10500000
CY2020Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	7100000
CY2019Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	10500000
CY2020Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	28700000
CY2020Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	33300000
CY2020Q2	us-gaap	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Undistributed Accumulated Earnings Of Foreign Subsidiary Existing Unrecognized Deferred Tax Liability TaxCutsAndJobsActOf2017IncompleteAccountingUndistributedAccumulatedEarningsOfForeignSubsidiaryExistingUnrecognizedDeferredTaxLiability	1000000.0
CY2019	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	1200000
CY2019Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	18900000
CY2020Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	20100000
CY2019Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	12600000
CY2019Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	18900000
CY2018Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	24800000
CY2017Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	15200000
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	3200000
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	4200000
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	100000
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	6200000
CY2019	syna	Unrecognized Tax Benefits Decreases Resulting From Remeasurement UnrecognizedTaxBenefitsDecreasesResultingFromRemeasurement	-2000000.0
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	2100000
CY2019	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1900000
CY2020Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	20100000
CY2019Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	18900000
CY2018	syna	Increase Decrease In Unrecognized Tax Benefit Income Tax Penalties And Interest Accrued IncreaseDecreaseInUnrecognizedTaxBenefitIncomeTaxPenaltiesAndInterestAccrued	700000
CY2020Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	1900000
CY2019Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	1900000
CY2020Q2	us-gaap	Decrease In Unrecognized Tax Benefits Is Reasonably Possible DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	1700000
CY2020Q2	us-gaap	Increase In Unrecognized Tax Benefits Is Reasonably Possible IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	2300000
CY2020	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2020	syna	Number Of Product Categories NumberOfProductCategories	3
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1333900000
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1472200000
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1630300000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1333900000
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1472200000
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1630300000
CY2020Q2	us-gaap	Noncurrent Assets NoncurrentAssets	538500000
CY2019Q2	us-gaap	Noncurrent Assets NoncurrentAssets	620600000

Files In Submission

Name	View Source	Status
0001564590-20-040946-index-headers.html	Edgar Link	pending
0001564590-20-040946-index.html	Edgar Link	pending
0001564590-20-040946.txt	Edgar Link	pending
0001564590-20-040946-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
gb3ht5hde2iu000001.jpg	Edgar Link	pending
gb3ht5hde2iu000002.jpg	Edgar Link	pending
gccfrjmuw5uv000001.jpg	Edgar Link	pending
gp4rky2aqzat000001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
syna-10k_20200627.htm	Edgar Link	pending
syna-10k_20200627_htm.xml	Edgar Link	completed
syna-20200627.xsd	Edgar Link	pending
syna-20200627_cal.xml	Edgar Link	unprocessable
syna-20200627_def.xml	Edgar Link	unprocessable
syna-20200627_lab.xml	Edgar Link	unprocessable
syna-20200627_pre.xml	Edgar Link	unprocessable
syna-ex1013_314.htm	Edgar Link	pending
syna-ex1014_313.htm	Edgar Link	pending
syna-ex21_13.htm	Edgar Link	pending
syna-ex22c_635.htm	Edgar Link	pending
syna-ex231_14.htm	Edgar Link	pending
syna-ex311_11.htm	Edgar Link	pending
syna-ex312_12.htm	Edgar Link	pending
syna-ex321_17.htm	Edgar Link	pending
syna-ex322_15.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SYNA
SYNAPTICS Inc Stock $syna

2019 Q2 Form 10-K Financial Statement

#000156459020040946 Filed on August 21, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SYNA SYNAPTICS Inc Stock $syna

2019 Q2 Form 10-K Financial Statement

#000156459020040946 Filed on August 21, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SYNA
SYNAPTICS Inc Stock $syna